The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kashtanova E.V.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences

Polonskaya Ya.V.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences

Scherbakova L.V.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences

Logvinenko I.I.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences

Kurtukov E.F.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences

Denisova D.V.

Research Institute of Therapy and Preventive Medicine — branch of Federal Research Center Institute of Cytology and Genetics

Ragino Yu.I.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences

Abdominal obesity and the level of markers of lower respiratory tract damage in patients with chronic bronchitis

Authors:

Kashtanova E.V., Polonskaya Ya.V., Scherbakova L.V., Logvinenko I.I., Kurtukov E.F., Denisova D.V., Ragino Yu.I.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2021;24(5): 35‑40

DOI: 10.17116/profmed20212405135

Views: 1601

Downloaded: 42

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Kashtanova EV, Polonskaya YaV, Scherbakova LV, Logvinenko II, Kurtukov EF, Denisova DV, Ragino YuI. Abdominal obesity and the level of markers of lower respiratory tract damage in patients with chronic bronchitis. Russian Journal of Preventive Medicine. 2021;24(5):35‑40. (In Russ.)
https://doi.org/10.17116/profmed20212405135

 
МСФ на ЯМ
Close metadata
Recommended articles:
Impact of meta­bolic para­meters and risk factors on surfactant proteins SP-A and SP-D in abdo­minal obesity. Russian Journal of Preventive Medi­cine. 2024;(7):60-66
Asso­ciations of adipocytokines and kidney function in young people with abdo­minal obesity. Russian Journal of Preventive Medi­cine. 2024;(8):53-59
Possibilities of vibroacoustic therapy application in patients with chro­nic bronchopulmonary pathology. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):12-18

Chronic bronchitis is a very acute problem not only in Russia, but also around the world. Recently, the literature describes the clinical and functional features of the combined course of chronic bronchitis and abdominal obesity, which is a predictor of an unfavorable prognosis of this pathology.

OBJECTIVE

To study the association of abdominal obesity with markers of lower respiratory tract damage such as surfactant proteins A and D, α1-antitrypsin, Clara cell protein, pulmonary and activation- regulated chemokine in patients with chronic bronchitis.

MATERIAL AND METHODS

The study included 64 patients who underwent a screening examination at the NIITPM branch of the ICiG SB RAS. The patients were interviewed for the detection of respiratory diseases, spirometry, and anthropometry. All patients were divided into two groups: 1—37 patients with chronic bronchitis (CKD) in combination with abdominal obesity, 2—27 patients with chronic bronchitis without abdominal obesity. Serum levels of serum surfactant protein A, serum surfactant protein D, α1-antitrypsin, Clara cell protein (CC16), and pulmonary and activation- regulated chemokine (PARC) were determined by enzyme immunoassay.

RESULTS

The level of serum surfactant protein D is significantly lower in the group of patients with CKD in combination with abdominal obesity. The content of PARC was 43% higher in the group of patients with abdominal obesity. In women, the level of PARC was increased by 1.42 times, and in men by 1.35 times. There were no statistically significant differences between the groups for serum surfactant protein A, α1-antitrypsin, and CC16. When conducting the correlation analysis revealed a connection between the level of lung CC chemokine regulated activation with BMI (r=0.499; p<0.01) and waist circumference (r=0.493; p<0.01).

CONCLUSION

In patients with chronic bronchitis, the presence of abdominal obesity is associated with a significant change in the levels of markers of lower respiratory tract damage, such as pulmonary and activation- regulated chemokine and surfactant protein D.

Keywords:

chronic bronchitis
abdominal obesity
surfactant A
surfactant D
α1-antitrypsin
Clara cell protein (CC16)
pulmonary and activation- regulated chemokine (PARC)

Authors:

Kashtanova E.V.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences

Polonskaya Ya.V.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences

Scherbakova L.V.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences

Logvinenko I.I.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences

Kurtukov E.F.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences

Denisova D.V.

Research Institute of Therapy and Preventive Medicine — branch of Federal Research Center Institute of Cytology and Genetics

Ragino Yu.I.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics of the Siberian Branch of Russian Academy of Sciences

Received:

30.11.2020

Accepted:

20.02.2021

List of references:

  1. Obshchaya zabolevaemost’ vsego naseleniya Rossii v 2017 godu. Statisticheskie materialy. Chast’ 2. M.: MZ RF; 2018. Accessed March 27, 2021. (In Russ.). https://www.rosminzdrav.ru/ministry/61/22/stranitsa-979/statisticheskie-i-informatsionnye-materialy/statisticheskiy-sbornik-2017-god
  2. Zammit C, Liddicoat H, Moonsie I, Makker H. Obesity and respiratory diseases. International Journal of General Medicine. 2010;3(4):335-343.  https://doi.org/10.2147/IJGM.S11926
  3. Boikov VA, Kobyakova OS, Deev IA, Kulikov ES, Starovoitova EA. The state of external respiratory function in obese patients. Bûlletenʹ sibirskoj mediciny. 2013;12(1):86-92. (In Russ.).
  4. Foumani AA, Neyaragh MM, Ranjbar ZA, Leyli EK, Ildari S, Jafari A.Waist Circumference and Spirometric Measurements in Chronic Obstructive Pulmonary Disease. Osong Public Health Res Perspect. 2019;10(4):240-245.  https://doi.org/10.24171/j.phrp.2019.10.4.07
  5. Behrens G, Matthews CE, Moore SC, Hollenbeck AR, Leitzmann MF Body size and physical activity in relation to incidence of chronic obstructive pulmonary disease. CMAJ. 2014;186(12):E457-469.  https://doi.org/10.1503/cmaj.140025
  6. Akpinar EE, Akpinar S, Ertek S, Sayin E, Gulhan M. Systemic inflammation and metabolic syndrome in stable COPD patients. Tuberkulozve Toraks. 2012;60:230-237.  https://doi.org/10.5578/tt.4018
  7. Vujic T, Nagorni O, Maric G, Popovic L, Jankovic J. Metabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammation. Hippokratia. 2016;20(2):110-114. 
  8. Kokosov AN. Chronic non-obstructive bronchitis. Klinicheskaya medicina. 1999;1:11-16. (In Russ.).
  9. Sin DD, Miller BE, Duvoix A, Man SF, Zhang X, Silverman EK, Connett JE, Anthonisen NA, Wise RA, Tashkin D, Celli BR, Edwards LD, Locantore N, Macnee W, Tal-Singer R, Lomas DA; ECLIPSE Investigators. Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(9):1187-1192. https://doi.org/10.1164/rccm.201008-1220OC
  10. Pinto-Plata V, Casanova C, Müllerova H, de Torres JP, Corado H, Varo N, Cordoba E, Zeineldine S, Paz H, Baz R, Divo M, Cortopassi F, Celli BR. Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD. Respir Res. 2012;13(1):71.  https://doi.org/10.1186/1465-9921-13-71
  11. Dilektasli AG, Demirdogen Cetinoglu E, Uzaslan E, Budak F, Coskun F, Ursavas A, Ercan I, Ege E. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization. Int J Chron Obstruct Pulmon Dis. 2017;12:199-208.  https://doi.org/10.2147/COPD.S118424
  12. Kishore U, Greenhough TJ, Waters P, Shrive AK, Ghai R, Kamran MF, Bernal AL, Reid KB, Madan T, Chakraborty T. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol. 2006;43(9):1293-1315. https://doi.org/10.1016/j.molimm.2005.08.004
  13. Orgeig S, Hiemstra PS, Veldhuizen EJ, Casals C, Clark HW, Haczku A, Knudsen L, Possmayer F. Recent advances in alveolar biology: evolution and function of alveolar proteins. Respir Physiol Neurobiol. 2010;173:43-54.  https://doi.org/10.1016/j.resp.2010.04.023
  14. Lyamina SV, Vedenikin TYu, Malyshev IYu. A modern approach to the analysis of the immune response in lung diseases: surfactant protein D and its role. Sovremennyye problemy nauki i obrazovaniya. 2011;4:1-4. (In Russ.).
  15. Hartl D, Griese M. Surfactant protein D in human lung diseases. Eur J Clin Invest. 2006;36(6):423-435.  https://doi.org/10.1111/j.1365-2362.2006.01648.x
  16. Ju CR, Liu W, Chen RC. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease. Dis Markers. 2012;32(5):281-287.  https://doi.org/10.3233/DMA-2011-0887
  17. Lomas DA, Silverman EK, Edwards LD, Locantore NW, Miller BE, Horstman DH, Tal-Singer R; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study investigators. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J. 2009;34(1):95-102.  https://doi.org/10.1183/09031936.00156508
  18. Shiels MS, Chaturvedi AK, Katki HA, Gochuico BR, Caporaso NE, Engels EA. Circulating markers of interstitial lung disease and subsequent risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2011;20(10):2262-2272. https://doi.org/10.1158/1055-9965.EPI-11-0326
  19. Sin DD, Leung R, Gan WQ, Man SP. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm Med. 2007;7:13.  https://doi.org/10.1186/1471-2466-7-13
  20. Winkler C, Atochina-Vasserman EN, Holz O, Beers MF, Erpenbeck VJ, Krug N, Roepcke S, Lauer G, Elmlinger M, Hohlfeld JM. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir Res. 2011;12:29.  https://doi.org/10.1186/1465-9921-12-29
  21. Shakoori TA, Sin DD, Ghafoor F, Bashir S, Bokhari SN. Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease. Dis Markers. 2009;27(6):287-294.  https://doi.org/10.3233/DMA-2009-0674
  22. Eisner MD, Parsons P, Matthay MA, Ware L, Greene K; Acute Respiratory Distress Syndrome Network. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax. 2003;58(11):983-988.  https://doi.org/10.1136/thorax.58.11.983
  23. Jawed S, Mannan N, Qureshi MA. Association of Surfactant Protein-D with Obesity. J Ayub Med Coll Abbottabad. 2016;28(3):489-492. 
  24. Broeckaert F, Clippe A, Knoops B, Hermans C, Bernard A. Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann NY Acad Sci. 2000;923:68-77.  https://doi.org/10.1111/j.1749-6632.2000.tb05520.x
  25. Guerra S, Vasquez MM, Spangenberg A, Halonen M, Martin RJ. Club cell secretory protein in serum and bronchoalveolar lavage of patients with asthma. J Allergy Clin Immunol. 2016;138:932-934.  https://doi.org/10.1016/j.jaci.2016.03.047
  26. Laucho-Contreras ME, Polverino F, Tesfaigzi Y, Pilon A, Cell BR, Owen CA. Club cell protein 16 (CC16) augmentation: a potential disease-modifying approach for chronic obstructive pulmonary disease (COPD). Expert Opin Ther Targets. 2016;20:8690-8883. https://doi.org/10.1517/14728222.2016.1139084
  27. Petersen H, Leng S, Belinsky SA, Miller BE, Tal-Singer R, et al. Low plasma CC16 levels in smokers are associated with higher risk for chronic bronchitis. Eur Respir J. 2015;46:1501-1503. https://doi.org/10.1183/13993003.00682-2015
  28. Guerra S, Vasquez MM, Spangenberg A, Halonen M, Martin RJ. Club cell secretory protein in serum and bronchoalveolar lavage of patients with asthma. J Allergy Clin Immunol. 2016;138(3):932-934.  https://doi.org/10.1016/j.jaci.2016.03.047
  29. Chuchalin AG, Tseymakh IYa, Momot AP, Mamaev AN, Karbyshev IA, Kostyuchenko GI. Changes in systemic inflammatory and hemostatic response in patients with co-morbidity of exacerbation of chronic obstructive pulmonary disease, chronic heart failure and obesity. Russian Pulmonology. 2014;6:25-32. (In Russ.). https://doi.org/10.18093/0869-0189-2014-0-6-25-32
  30. Shijubo N, Itoh Y, Yamaguchi T, et al. Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers. Eur Respir J. 1997;10(5):1108-1114. https://doi.org/10.1183/09031936.97.10051108
  31. Rava M, Tares L, Lavi I, et al. Serum levels of Clara cell secretory protein, asthma, and lung function in the adult general population. J Allergy Clin Immunol. 2013;132(1):230-232.  https://doi.org/10.1016/j.jaci.2013.01.023

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.